|Bid||8,616.00 x 0|
|Ask||8,616.00 x 0|
|Day's range||8,553.00 - 8,720.00|
|52-week range||6,499.80 - 8,848.00|
|Beta (5Y monthly)||0.19|
|PE ratio (TTM)||39.65|
|Earnings date||12 Nov 2021|
|Forward dividend & yield||2.02 (2.37%)|
|Ex-dividend date||12 Aug 2021|
|1y target est||N/A|
The British biotech company said on Wednesday it will receive an investment of just over £50m from the Institute.
Serum Life Sciences Ltd, a unit of India-based SII, will pick up a 3.9% stake in Oxford Biomedica as part of the deal. Oxford Biomedica, spun off from Oxford University in 1995, said it would use the funds to develop the fallow area at its Oxbox plant into a manufacturing space expected to come online in mid-2023. Shares of the British firm were up 5% on the London Stock Exchange, as of 0745 GMT.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...